Balancing Act: Why Healthcare Can't Choose Between AI Innovation And Sustainability

Balancing Act: Why Healthcare Can't Choose Between AI Innovation And Sustainability

NORTHAMPTON, MA / ACCESS Newswire / November 24, 2025 / Raman Venkatesh, Medtronic Chief Sustainability Officer, and Rodolphe Katra, Medtronic Chief Artificial Intelligence (AI) Officer, on how we can advance innovation and sustainability in healthcare simultaneously

Healthcare is experiencing a transformation that seemed impossible just a few years ago. AI is detecting diseases earlier, personalizing treatments with unprecedented precision, and delivering complex care in more accessible settings. It's driving measurable and meaningful improvements in patient outcomes, workflow efficiency, and care accessibility. It's raising the standard of care around the world.

Yet, there's another impact we need to discuss: AI is also resource-intensive. With $3 trillion projected to be invested in AI by 2028, its energy and water consumption has rightfully raised concerns.

Some estimates suggest that without new capacity, AI could consume over 9% of the U.S. electricity grid in the next decade, up from nearly 3% today.

It'd be easy to frame this as a binary choice - innovation or sustainability. But that's not realistic, and it's not responsible. Healthcare can't afford to prioritize one at the expense of the other, even when weighing healthcare benefits against environmental costs can become impossibly complex. We need to be pragmatic about how we can advance both simultaneously without compromising on either.

So, let's talk about what it will take to get this balance right.

Welcome to Healthcare 5.0

We're entering an era defined by ultra-personalized, predictive, and preventive care - Healthcare 5.0. It's a fundamental shift in how we deliver care that's possible as we harness the power of AI.

Diagnostic tools leveraging AI are enabling earlier, more precise disease detection. The AI-powered GI Genius™ improves colonoscopy detection rates by up to 14%, helping physicians identify polyps they might otherwise miss. Aside from the direct patient health outcome benefit, better detection leads to earlier intervention, which can help prevent more resource-intensive treatments down the line.

Personalized treatment planning also shows real, measurable results. Spinal surgery using patient-specific alignment, such as the UNiD™ adaptive spine intelligence (ASI) system, has been shown to lower revision rates compared to traditional approaches. While this approach may require more resources initially, eliminating the need for a potential second surgery mitigates future consumption and delivers a superior patient experience. In addition, AI-enabled spinal surgery planning can provide predictable and reproducible outcomes for patients with spinal deformity.

AI and digital tools are also redefining where and how care is delivered. Digital capabilities, such as the Touch Surgery™ ecosystem, are being explored for ambulatory settings where using Live Stream enables access to experts from elsewhere. In an emergency or at a remote location, these tools support and augment on-site staff. Moving complex care from hospitals to outpatient centers also dramatically reduces resource use since hospitals generate an estimated over 29 pounds of waste per bed per day. Ambulatory care requires a fraction of that infrastructure while making care more accessible and affordable.

When it comes to workflow, AI is helping healthcare systems do more with what they have. Early data shows AI could be used to augment or automate 70% of healthcare workers' tasks, allowing organizations to serve more patients without expanding infrastructure. As an example, Medtronic's own LINQ II™ insertable cardiac monitor - deploying AccuRhythm™ AI algorithms - can save clinicians 400 hours annually of false alert reviews for every 200 patients they serve. Accomplishing more with existing resources is an efficiency that matters for both business and the planet.

It also matters for individual clinicians. By reducing administrative burden, AI can free up time for patient interactions and help address burnout.

The measurement challenge

Here's where it gets complicated. Current sustainability metrics focus heavily on immediate environmental impacts - the energy consumed by a query or the water used to cool a data center. They don't capture the full life cycle impacts of AI-enabled healthcare.

The industry needs frameworks that can meaningfully compare the environmental costs of AI against the healthcare value it creates. How do we measure the resources AI consumes against avoided hospital stays, prevented complications, or lives extended? AI's ability to improve outcomes, efficiency, and accessibility creates value that must factor into sustainability discussions. And we need reliable and industry-wide measurement frameworks sophisticated enough to capture both sides of the equation.

It's also worth noting that, from a resource-consumption perspective, not all AI is created equal. At Medtronic, we focus primarily on closed-loop AI models that operate within established knowledge paradigms - algorithmic AI that's far less resource-intensive than large language models analyzing vast universes of open data. It's an important distinction since generative AI applications require significantly more computational power, while the algorithmic AI embedded in some of our medical devices operates efficiently in more contained environments.

Healthcare companies can't solve this alone. Enterprise AI providers and cloud computing partners need to measure AI efficiency using metrics that attempt to quantify AI's performance against the resources consumed - something like "tokens per watt per gallon of water," perhaps. The measurement challenge is as much about cross-industry collaboration as it is about developing the right metrics.

Practicing the balancing act

So, what can we do?

First, we need strategic AI deployment. Not every problem requires the most computationally intensive solution. The principle should be simple: Use the right AI tool for the right job, and only deploy AI when it demonstrably improves a healthcare success metric. This is what responsible AI should be about - particularly in healthcare, where, unlike other generative AI applications, there should be zero tolerance for hallucinations or clinically indefensible outputs. AI for AI's sake is part of the problem.

This requires governance systems within companies that guide appropriate tool selection, helping teams match computational intensity to problem complexity while maximizing the benefit created.

We also need perspective on technology maturation. History shows us that emerging technologies become more efficient and cost-effective over time: Solar panels are 40% more efficient than in 2010, while electric vehicle battery energy density has boosted typical ranges from 100 miles per charge to 250-400 miles in around a decade. AI is following the same trajectory, with new chip architectures delivering more computational power while using less energy, and smaller models proving you don't always need the biggest solution.

We should manage AI's environmental impact early in its adoption, but we should also be realistic about giving it time to mature.

In the meantime, there are concrete steps we can take. Medtronic is investing in renewable energy at scale - our recent virtual power purchase agreement adds renewable energy equivalent to nearly all our North American energy needs. We're modernizing facilities with more efficient technology and partnering with AI providers committed to sustainable practices. These aren't perfect solutions, but they're actions we can take today.

To learn more about our approach, see the Medtronic FY25 Impact Report.

The path forward

The path forward requires holding two truths simultaneously: AI is driving essential healthcare innovation that improves lives, and AI has environmental impacts we must actively manage. Healthcare leaders need to develop measurement frameworks that capture full life cycle value, implement mitigation strategies now, and collaborate across industries to create sustainable practices.

Healthcare has always faced a twin impact from climate change - the healthcare industry contributes roughly 5% of global greenhouse gas emissions while concurrently treating the adverse health effects caused by environmental pollution and climate change. That creates a compounding burden we can't ignore.

This isn't about choosing between innovation and sustainability. It's about pursuing both with equal commitment, measuring honestly, implementing strategically, and collaborating broadly.

The healthiest future is one in which AI advancement and environmental sustainability aren't opposing forces but integrated imperatives driving healthcare forward together.

Medtronic's GI Genius(TM): AI-driven polyp detection during colonoscopy

View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com.

Contact Info:
Spokesperson: Medtronic
Website: https://www.3blmedia.com/profiles/medtronic
Email: info@3blmedia.com

SOURCE: Medtronic



View the original press release on ACCESS Newswire

News Provided by ACCESS Newswire via QuoteMedia

MDT
The Conversation (0)
New Found Gold Announces Participation in Upcoming Mining Conferences, Including Precious Metals Summit and Mining Forum Americas 2025

New Found Gold Announces Participation in Upcoming Mining Conferences, Including Precious Metals Summit and Mining Forum Americas 2025

New Found Gold Corp. (" New Found Gold " or the " Company ") (TSXV: NFG) (NYSE-A: NFGC) is pleased to announce the Company will be participating in several upcoming conferences, including the Precious Metals Summit and Mining Forum Americas 2025. The focus of these conferences will be to discuss... Keep Reading...
Pine Cliff Energy Ltd. Announces First Quarter 2024 Results and Information Regarding the Annual Meeting of Shareholders

Pine Cliff Energy Ltd. Announces First Quarter 2024 Results and Information Regarding the Annual Meeting of Shareholders

Pine Cliff Energy Ltd. (TSX: PNE) ("Pine Cliff" or the "Company") announces its first quarter 2024 financial and operating results, an operational update and information regarding the annual meeting of shareholders. First Quarter 2024 Results Results for the three months ended March 31, 2024 are... Keep Reading...

Canadian Natural Resources Limited Announces 2024 First Quarter Results

Canadian Natural's (TSX: CNQ) (NYSE: CNQ) President, Scott Stauth, commented on the Company's first quarter results, "Canadian Natural is a world class company and during our 35 years of operations, we've delivered significant value, including recently reaching a position where, commencing in... Keep Reading...
Pine Cliff Energy Ltd. Announces Appointment of Officers, Declares Monthly Dividend for May 31, 2024 and First Quarter 2024 Webcast Details

Pine Cliff Energy Ltd. Announces Appointment of Officers, Declares Monthly Dividend for May 31, 2024 and First Quarter 2024 Webcast Details

Pine Cliff Energy Ltd. (TSX: PNE) (OTCQX: PIFYF) ("Pine Cliff" or the "Company") is pleased to announce the appointments of Mr. Daniel Keenan P. Eng to the position of Vice President Exploitation and Mr. Austin Nieuwdorp CA, CPA to the position of Vice President Finance and Controller both... Keep Reading...
ATCO Ltd. to Share Strategic Update at Annual General Meeting on May 15, 2024

ATCO Ltd. to Share Strategic Update at Annual General Meeting on May 15, 2024

ATCO Ltd. (TSX: ACO.X) (TSX: ACO.Y) ATCO Ltd. (ATCO) will hold its 57th Annual General Meeting of share owners at 10 a.m. MDT on Wednesday , May 15, 2024. In addition to the formal business of the meeting, attendees will hear management's view of ATCO's full year 2023 and first quarter 2024... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...

Latest Press Releases

Related News